126 related articles for article (PubMed ID: 38336289)
1. Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer.
Zhao G; Forn-Cuní G; Scheers M; Lindenbergh PP; Yin J; van Loosen Q; Passarini L; Chen L; Snaar-Jagalska BE
Cancer Lett; 2024 Apr; 587():216657. PubMed ID: 38336289
[TBL] [Abstract][Full Text] [Related]
2. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
[TBL] [Abstract][Full Text] [Related]
3. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
Roca H; Varsos ZS; Pienta KJ
Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
5. CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo.
Yan Y; Du C; Li G; Chen L; Yan Y; Chen G; Hu W; Chang L
Urol Oncol; 2018 Jun; 36(6):312.e1-312.e8. PubMed ID: 29566977
[TBL] [Abstract][Full Text] [Related]
6. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
[TBL] [Abstract][Full Text] [Related]
8. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
9. Ethanol extract of Remotiflori radix induces endoplasmic reticulum stress-mediated cell death through AMPK/mTOR signaling in human prostate cancer cells.
Kim A; Im M; Ma JY
Sci Rep; 2015 Feb; 5():8394. PubMed ID: 25670261
[TBL] [Abstract][Full Text] [Related]
10. Impaired Cellular Energy Metabolism Contributes to Duck-Enteritis-Virus-Induced Autophagy via the AMPK-TSC2-MTOR Signaling Pathway.
Yin H; Zhao L; Li S; Xu L; Wang Y; Chen H
Front Cell Infect Microbiol; 2017; 7():423. PubMed ID: 29018776
[TBL] [Abstract][Full Text] [Related]
11. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758
[TBL] [Abstract][Full Text] [Related]
12. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
13. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.
Akasaka Y; Hasei S; Ohata Y; Kanna M; Nakatsu Y; Sakoda H; Fujishiro M; Kushiyama A; Ono H; Matsubara A; Hinata N; Asano T; Yamamotoya T
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958994
[No Abstract] [Full Text] [Related]
14. Cross-talk between AMPK and mTOR in regulating energy balance.
Xu J; Ji J; Yan XH
Crit Rev Food Sci Nutr; 2012; 52(5):373-81. PubMed ID: 22369257
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
[TBL] [Abstract][Full Text] [Related]
16. A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth.
Plews RL; Mohd Yusof A; Wang C; Saji M; Zhang X; Chen CS; Ringel MD; Phay JE
J Clin Endocrinol Metab; 2015 May; 100(5):E748-56. PubMed ID: 25710562
[TBL] [Abstract][Full Text] [Related]
17. The mixed blessing of AMPK signaling in Cancer treatments.
Sadria M; Seo D; Layton AT
BMC Cancer; 2022 Jan; 22(1):105. PubMed ID: 35078427
[TBL] [Abstract][Full Text] [Related]
18. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR
Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
20. Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells.
Yu Y; Hou L; Song H; Xu P; Sun Y; Wu K
Mol Cell Biochem; 2017 Jan; 424(1-2):173-183. PubMed ID: 27796683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]